Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
出版年份 2014 全文链接
标题
Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
作者
关键词
-
出版物
Chemical Science
Volume 5, Issue 6, Pages 2398
出版商
Royal Society of Chemistry (RSC)
发表日期
2014-03-31
DOI
10.1039/c4sc00451e
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- On-Chip Synthesis and Screening of a Sialoside Library Yields a High Affinity Ligand for Siglec-7
- (2013) Cory D. Rillahan et al. ACS Chemical Biology
- C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy
- (2013) Sørge Kelm et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting CD22 in B-cell Malignancies: Current Status and Clinical Outlook
- (2013) Loretta Sullivan-Chang et al. BIODRUGS
- Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
- (2013) Matthew S. Macauley et al. JOURNAL OF CLINICAL INVESTIGATION
- Copresentation of Antigen and Ligands of Siglec-G Induces B Cell Tolerance Independent of CD22
- (2013) F. Pfrengle et al. JOURNAL OF IMMUNOLOGY
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
- (2013) N. Kawasaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Click and Pick: Identification of Sialoside Analogues for Siglec-Based Cell Targeting
- (2012) Cory D. Rillahan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
- (2012) R. B. Walter et al. BLOOD
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
- (2012) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
- (2012) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- In Silico-Aided Design of a Glycan Ligand of Sialoadhesin for in Vivo Targeting of Macrophages
- (2012) Corwin M. Nycholat et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
- (2012) Hagop Kantarjian et al. LANCET ONCOLOGY
- Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
- (2012) Takumi Kiwamoto et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy
- (2011) Camilla Jandus et al. BIOCHEMICAL PHARMACOLOGY
- CD22-Antagonists with nanomolar potency: The synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold
- (2011) Hajjaj H.M. Abdu-Allah et al. BIOORGANIC & MEDICINAL CHEMISTRY
- High affinity sialoside ligands of myelin associated glycoprotein
- (2011) Ying Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- From a Library of MAG Antagonists to Nanomolar CD22 Ligands
- (2011) Stefanie Mesch et al. ChemMedChem
- A Sialylated Glycan Microarray Reveals Novel Interactions of Modified Sialic Acids with Proteins and Viruses
- (2011) Xuezheng Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- In vivo targeting of B-cell lymphoma with glycan ligands of CD22
- (2010) W. C. Chen et al. BLOOD
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- (2010) Michinori Ogura et al. CANCER SCIENCE
- Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
- (2010) Anjali Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells
- (2010) M. K. O'Reilly et al. JOURNAL OF IMMUNOLOGY
- Low Molecular Weight Antagonists of the Myelin-Associated Glycoprotein: Synthesis, Docking, and Biological Evaluation
- (2010) Stefanie Mesch et al. JOURNAL OF MEDICINAL CHEMISTRY
- Basic and Clinical Immunology of Siglecs
- (2009) Stephan von Gunten et al. Annals of the New York Academy of Sciences
- Potent small molecule mouse CD22-inhibitors: Exploring the interaction of the residue at C-2 of sialic acid scaffold
- (2009) Hajjaj H.M. Abdu-Allah et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
- (2009) Bao Hoa Duong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Siglecs as targets for therapy in immune-cell-mediated disease
- (2009) Mary K. O’Reilly et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Design, Synthesis, and Structure−Affinity Relationships of Novel Series of Sialosides as CD22-Specific Inhibitors
- (2008) Hajjaj H. M. Abdu-Allah et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sialoside Analogue Arrays for Rapid Identification of High Affinity Siglec Ligands
- (2008) Ola Blixt et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now